Advertisement

Global Rising Tides Associated with Pharmaceuticals

  • Satoru Kimura
  • Yasuhide Nakamura
Chapter
Part of the Trust book series (TRUST, volume 5)

Abstract

Quality-related problems in pharmaceutical products have become globalized by interactions among several events which occurred within networks involving pharmaceuticals. The events include, among others, greater prominence of pharmaceutical industries in emerging countries and complementary structures between the emerging and the developed markets; expanding wealth gap between poor and rich; remarkable progress of large-scale pharmaceutical companies in developed countries and their influential power; the group consisting of developed countries that contribute to quality improvement; the HIV/AIDS pandemic; the public health issues in emerging and developing countries; and monopoly of intellectual property rights by developed countries. Observing the events which occurred amid times of globalization that mutually interacted with one another within these networks help us to better understand the problems associated with poor quality drugs occurring simultaneously with globalization. Observing these events using data obtained from the Google Ngram Viewer provides a visual understanding of the situation in which the occurrence of these events was concentrated across several decades of globalization. The authors discuss global events which became tangled with one another and lead to the global spread of poor quality drugs, and organize and prepare the information necessary for analysis in the next chapter.

Keywords

BRICs Globalization HIV/AIDS Intellectual property Poverty Substance patent 

References

  1. Africa Japan Forum. 2003. Koheizuyaku he no Akusesu [Access to Anti-HIV Drugs]. https://www.google.com/search?hl=ja&hq=inurl%3Awww.ajf.gr.jp&ie=Shift_JIS&oe=Shift_JIS&filter=0&q=TRIPs&submit.x=8&submit.y=9. (In Japanese) Accessed 22 March 2014.
  2. Aiden, Erez and Jean-Baptiste Michel. 2013. Uncharted: Big Data as a Lens on Human Culture. Trans. Erez Lieberman Aiden and Jean-Baptiste Michel.Google Scholar
  3. Bremmer, I. 2016. Tojokoku mo Manseibyo Taisaku ga Kyumu [Urgent Action Needed for Chronic Diseases in Developing Countries]. Nihon Keizai Shimbun, May 30. (In Japanese).Google Scholar
  4. Kato, Akiko. 2003. WTO no TRIPs Kyotei ni okeru Iyakuhin Kanren Hatsumei Hogo Seido no Zanshinteki Hatten -Tokkyoken wo Chuhshin ni- [Step-by-step Development of Protection System for Medicine-related Inventions in the TRIPS Agreement of WTO]. http://www.iip.or.jp/summary/pdf/detail02j/14_19.pdf. (In Japanese). Accessed 4 Sept 2016.
  5. Meadows, D., J. Randers, and D. Meadows. 2004. Limits to Growth the 30-Year Update. Trans. Earthscan.Google Scholar
  6. Mori, Makoto. 1994. Tokyo no Bunmeisi [History of Patents from the Perspective of Civilization]. Tokyo: Shinchosya.Google Scholar
  7. Steger, M.B. 2009. Globalization: A Very Short Introduction. Trans. Oxford: Oxford University Press.Google Scholar
  8. Teshigawara, Kayoko. 2013. Iryo Akusesu to Gurohbarizeshon –Firipin no Noson Chiiki wo Jirei to shite [Access to Healthcare Services and Globalization -A Case Study on Agricultural Communities in the Philippines]. Tokyo: Akshi Shoten. (In Japanese).Google Scholar
  9. Tsutsumi, Mika. 2008. Rupo Hinkon Taikoku Amerika [Reportage -USA: A Power in Poverty-]. Tokyo: Iwanami Shinsho. (In Japanese).Google Scholar
  10. WHO. 2004. 11th International Conference of Drug Regulatory Authorities (Madrid, 16–19 February 2004. http://www.who.int/medicines/publications/druginformation/ICDRA11_proceedings.pdf?ua=1. Accessed 9 Nov 2014.
  11. Wikipedia. Information asymmetry. https://ja.wikipedia.org/wiki/. Accessed 1 July 2018.
  12. World Bank. 2014. World Development Report 2014 Risk and Opportunity-Managing Risk for Development. Trans. Washington, DC. https://openknowledge.worldbank.org/handle/10986/16092. Accessed 1 Sept 2018.
  13. Yamane, Hiroko. 2008. Chiteki Zaisanken no Gurobaruka -Iyakuhin Akusesu to TRIPS Kyotei- [Globalization of Intellectual Property Rights -Access to Medicines and TRIPS Agreement-]. Tokyo: Iwanami Shoten. (In Japanese).Google Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2020

Authors and Affiliations

  • Satoru Kimura
    • 1
  • Yasuhide Nakamura
    • 2
  1. 1.Department of Reference StandardsPharmaceutical and Device Regulatory Science Society of JapanOsakaJapan
  2. 2.School of Nursing and RehabilitationKonan Women’s UniversityKobeJapan

Personalised recommendations